Interstitial Cystitis and Female Sexual Dysfunction

Objectives To use the Female Sexual Function Index (FSFI) to compare female sexual dysfunction in patients with interstitial cystitis/painful bladder syndrome (IC) with that in controls. Methods Consecutive patients with IC and asymptomatic controls were tested for voiding diary voided volumes, Pelv...

Full description

Saved in:
Bibliographic Details
Published inUrology (Ridgewood, N.J.) Vol. 69; no. 4; pp. 608 - 610
Main Authors Ottem, Derek P, Carr, Lesley K, Perks, Alexandra E, Lee, Patricia, Teichman, Joel M.H
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.04.2007
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives To use the Female Sexual Function Index (FSFI) to compare female sexual dysfunction in patients with interstitial cystitis/painful bladder syndrome (IC) with that in controls. Methods Consecutive patients with IC and asymptomatic controls were tested for voiding diary voided volumes, Pelvic Pain and Urgency/Frequency Questionnaire scores, and FSFI scores. Results Of the 97 subjects, 75 had IC and 22 were controls. The mean age was 38 and 43 years ( P = 0.09), the voided volume was 165 mL and 294 mL ( P <0.0001), and the Pelvic Pain and Urgency/Frequency Questionnaire score was 18 versus 3 ( P <0.0001) for the IC and control groups, respectively. The total adjusted FSFI scores differed between patients with IC and the controls (20.2 ± 9.6 versus 29.0 ± 6.8, respectively, P <0.001). Using 26.55 as the cutpoint, 51 patients with IC (68%) had an abnormal FSFI score versus 3 controls (14%; P <0.001). Patients with IC scored worse on all domains of female sexual dysfunction than did the controls ( P <0.01). Conclusions The results of our study have shown that female patients with IC have sexual dysfunction, including pain, more commonly than do controls.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0090-4295
1527-9995
DOI:10.1016/j.urology.2006.12.024